3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
11
Sarcoma
6
Neoplasms
6
Lymphoma, Mantle-Cell
6
Prostatic Neoplasms
5
Lymphoma, Non-Hodgkin
5
Rhabdomyosarcoma
4
Neoplasm Metastasis
4
Kidney Neoplasms
4
Gliosarcoma
4
Glioblastoma
4
Breast Neoplasms
4
Brain Neoplasms
4
Waldenstrom Macroglobulinemia
3
Osteosarcoma
3
Melanoma
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Endometrial Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Liposarcoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Glioma
2
Fallopian Tube Neoplasms
2
Carcinoma, Hepatocellular
2
Interventions
Cyclophosphamide
34
fludarabine
25
fludarabine phosphate
24
Tacrolimus
24
Mycophenolic Acid
23
Whole-Body Irradiation
22
Busulfan
15
Methotrexate
12
Melphalan
12
Granulocyte Colony-Stimulating Factor
12
Antilymphocyte Serum
12
thymoglobulin
11
Cyclosporine
11
Stem Cell Transplantation
10
Filgrastim
10
Rituximab
9
Thiotepa
7
Peripheral Blood Stem Cell Transplantation
7
Nivolumab
7
Dexamethasone
7
trametinib
6
Radiotherapy
6
Mesna
6
Cytarabine
6
Prednisone
5
Calcium Dobesilate
5
Bortezomib
5
Azacitidine
5
Alemtuzumab
5
Voriconazole
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hematologic Neoplasms
×
temsirolimus
×
Clear all
No trials found.